dr. Rory de Vries wins Beijerinck Virology Premium for young virologists

Rory de Vries (born 1982) is receiving the premium for his research on the human body’s defences against respiratory viral infections, and for his ability to communicate his knowledge of virology and infectious diseases to a wide audience. Rory de Vries is a post-doctoral researcher at Erasmus MC in Rotterdam.

Awards ceremony

The KNAW Beijerinck Premium is presented on Friday 8 March after the conclusion of the Dutch Annual Virology Symposium (DAVS).

For more information, see knaw.nl/en-days

Want to know more about dr.Rory de Vries? Read here.

Want to read more about the Beijerinck Virology prize? Read here.

More News

Kick-off Young NCOH network

Young NCOH is the network for PhD students and post-docs from the NCOH research groups. Aim of the network is sharing knowledge and expertise in One Health-related disciplines, which can lead to new collaborations in research. The kick-off of the network takes place at the Annual Scientific Meeting, 17 May 2019 (ASM2019).

More

One Health debate

On Thursday, 28 February 2019, the ‘One Health’ debate will take place in The Hague. This debate is the conclusion of the Castellum research programme: a public-private partnership aimed at developing vaccines against zoonoses.

More

Antibiotic resistance in the Netherlands under control

Contamination with resistant bacteria in patients admitted to Dutch hospitals does not result in higher mortality than contamination by non-resistant bacteria. Although the problem of antibiotic resistance in the Netherlands currently seems manageable, it is important to remain vigilant in view of the ever-changing epidemiology of resistant bacteria, according to Wouter Rottier, who was awarded... More

Volunteering to become ill to help researchers

Radboudumc has combined its research into controlled human infection models to create a new program: the Radboudumc Controlled Human Infection Models (RCHIM). By studying the interaction between pathogens and humans under controlled conditions, researchers can improve their understanding of the underlying disease mechanisms. This understanding contributes to a more targeted development of medicines and vaccines... More